Diffuse large B cell lymphoma (DLBCL) is the most common form of blood cancer and is
characterized by a striking degree of genetic and clinical heterogeneity. This heterogeneity …

INTRODUCTION The emergence of three lethal coronaviruses in <20 years and the urgency
of the COVID-19 pandemic have prompted efforts to develop new therapeutic strategies, …

Natural killer (NK)/T-cell lymphomas failing L-asparaginse regimens have no known salvage
and are almost invariably fatal. Seven male patients with NK/T-cell lymphoma (median age, …

Few studies have examined Chinese patients with chronic hepatitis B who exhibit hepatitis
B surface antigen (HBsAg) seroclearance. We comprehensively studied the biochemical, …

Natural killer/T-cell lymphoma is rare and aggressive, with poor outcome. Optimal treatment
remains unclear. A novel regimen dexamethasone, methotrexate, ifosfamide, l-asparaginase…

Natural killer (NK)/T-cell lymphomas and NK-cell leukemias are aggressive malignancies.
Occurring worldwide, they show a predilection for Asian and South American populations. …

The programmed cell death protein 1 (PD1) is one of the checkpoints that regulates the
immune response. Ligation of PD1 with its ligands PDL1 and PDL2 results in transduction of …

Extranodal natural killer (NK)/T-cell lymphoma is an aggressive malignancy of putative NK-cell
origin, with a minority deriving from the T-cell lineage. Pathologically, the malignancy …

We describe Livenotes, a shared whiteboard system and educational practice that uses
wireless communication and tablet computing to support real-time conversations within small …

Expression of antibodies inside cells has been used successfully to ablate protein function.
This finding suggests that the technology should have an impact on disease treatment and in …